Series B

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

Finnish defense firm Sensofusion buys aircraft maker Atol Aviation, shifting counter-drone warfare from the ground to the sky in a major strategic leap.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

With a key data readout looming for its chronic cough drug, Nocion adds a renowned dealmaker to its board, fueling speculation of a potential acquisition.

After 11 straight quarters of growth, clean nail care pioneer MiniLuxe lands new funding. Discover how its tech-driven, ethical model is winning.

With its lead drug for a rare pediatric liver disease entering late-stage trials, NorthSea Therapeutics adds a veteran drug developer to its board.

New research shows parents welcome corporate sponsors in schools to fill funding gaps, creating a powerful new marketing channel built on community trust.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

Pixee Medical's AR glasses are challenging costly robots, offering surgeons a new, highly accurate, and efficient way to perform knee replacements.

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

DMZ's summit channels $210,000 to women-led startups, signaling a strategic push into Canada’s critical AI, defence, and cybersecurity sectors.

With a history of billion-dollar deals, Mark Altmeyer takes the helm at ReproNovo, aiming to commercialize its promising fertility and women's health pipeline.

Woodrow AI has launched a specialized agent for finance teams, promising the accuracy and audit trails that have kept AI out of the back office until now.

The fast-growing vet chain hits a major milestone, but its venture-backed model reveals both the future of pet care and the challenges of rapid growth.

A new collaboration aims to predict immunotherapy success by mapping protein interactions, offering hope for personalized non-small cell lung cancer treatment.

Techstars names NEXT powered by Shulman Rogers an official partner, granting founders access to fixed-fee legal services and a new AI-powered fundraising platform.

With a new $60M fund and a former Lightspeed president, Boreal Ventures aims to turn great Canadian products into global commercial successes.

Fintech leader Momnt appoints Allyson Torsak as CRO, signaling a major push to capture the fragmented home improvement market with its advanced lending tech.

Billionaire-backed PEAK6 is paying founders a $100K salary to build fintech unicorns in Austin, challenging the traditional startup accelerator model.